Paul Mann to resume CEO role at ASP Isotopes on Jan 19, 2026; Ainscow returns to COO

ASP Isotopes Inc.

Founder/Exec Chairman Paul Mann reassumes CEO role effective Jan 19, 2026, after medical leave.
Interim CEO Robert Ainscow will continue as COO; no new compensatory arrangements disclosed.
The transition is a planned succession; no agreement with any other person for Mann's appointment.
Mann's biographical info is incorporated from the Nov 25, 2025 proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.